Lv1
50 积分 2025-03-18 加入
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
7天前
已完结
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors
7天前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
19天前
已完结
Lipid nanoparticle–mediated in vivo generation of panCAR immune cells for solid tumor immunotherapy
27天前
已完结
Eythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
1个月前
已完结
In vivo nano-engineering T cells for CAR-T therapy
2个月前
已完结
Bioorthogonal chemistry
3个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
3个月前
已完结
T-cell-engaging bispecific antibodies in cancer
3个月前
已完结
皖公网安备34019202002308
